Among the companies whose shares are expected to actively trade
in Friday's session are Aveo Pharmaceuticals Inc. (AVEO) and Valero
Energy Corp. (VLO).
Aveo Pharmaceuticals said in a regulatory filing it received a
subpoena from the U.S. Securities and Exchange Commission
requesting documents and information concerning tivoznib, which the
U.S. Food and Drug Administration declined to approve for the
treatment of patients with advanced renal cell carcinoma. Shares
fell 12% to $2.23 after hours.
Valero expects its second-quarter profit to fall short of
analysts' estimates, as its refining earnings are hit by rising
crude oil prices. Shares fell 4.3% after hours to $33.07.
Watchlist:
AngioDynamics Inc.'s (ANGO) fiscal fourth-quarter loss narrowed
as the medical-device company reported sales growth from its
oncology and surgery business.
Bank of the Ozarks Inc.'s (OZRK) second-quarter earnings rose
6.8% as the regional bank's interest income and non-interest income
both improved.
Dell Inc.'s (DELL) special committee dismissed activist investor
Carl Icahn's push for shareholders to seek an appraisal of their
shares, saying the move would involve substantial risks and costs.
Mr. Icahn also told Bloomberg TV Thursday he is pledging to offer a
warrant to his tender offer for Dell and said he would have a
"higher" bid for Dell by Friday morning.
H&R Block Inc. (HRB) agreed to sell the assets and
liabilities of H&R Block Bank to Republic Bank and Trust Co.,
allowing the tax-preparation company to exit the banking
business.
Terreno Realty Corp. (TRNO) plans to sell 5 million shares, as
the owner of industrial property seeks to pay down debt. The
company had about 19.2 million shares outstanding as of May 6.
Write to Nathalie Tadena at nathalie.tadena@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires